Clinical Trial Update: Effectiveness and Cost-effectiveness of a Pre-emptive Genotyping Strategy in Patients Receiving Tacrolimus [Phase 4]

View source ↗

Summary

Phase 4 trial evaluating whether pre-emptive genotyping to guide tacrolimus dosing improves effectiveness and cost-effectiveness in kidney transplant recipients…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Chronic Kidney Disease
• Kidney Transplantation

Drugs mentioned

• Tacrolimus (Tacrolimus)

Snippet

Sponsor: Instituto de Investigación Hospital Universitario La Paz | Conditions: Kidney Disease, Chronic, Transplant Recipient (Kidney) | Phase 4 | Status: RECRUITING